1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Pathology Analysis & Statistics in Germany, July 2020

Pathology Analysis & Statistics in Germany, July 2020

1-30 of about 1300 reports

Hemophilia A– Epidemiology—2030

  • $ 3750
  • Jul 2020
  • 120 pages

Hemophilia A– Epidemiology—2030 report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology of Hemophilia A in the United States, EU5 (Germany, France, Italy, ...

  • Blood Disease
  • Pathology
  • Germany
  • United Kingdom
  • United States

Diabetic Peripheral Neuropathy (DPN) - Epidemiology Forecast-2030

  • $ 3750
  • Jul 2020
  • 80 pages

‘Diabetic Peripheral Neuropathy (DPN) - Epidemiology Forecast-2030’ report deliver an in-depth understanding of the disease, historical & forecasted epidemiology trends of Diabetic Peripheral Neuropathy ...

  • Mental Health
  • Neurological Disorder
  • Pathology
  • Germany
  • United States

2020 Roche: US, Europe, Japan--Diagnostics Market Shares and Competitive Position by Product and Country--Performance, Capabilities, Goals and Strategies

  • $ 2450
  • July 2020
  • 128 pages

2020 Roche: US, Europe, Japan--Diagnostics Market Shares and Competitive Position by Product and Country--Performance, Capabilities, Goals and Strategies This unique market intelligence report provides ...

  • Diagnostics
  • Hepatitis
  • Pathology
  • Germany
  • United States

2020 DiaSorin: US, Europe, Japan--Diagnostics Market Shares and Competitive Position by Product and Country--Performance, Capabilities, Goals and Strategies

  • $ 2450
  • July 2020
  • 54 pages

2020 DiaSorin: US, Europe, Japan--Diagnostics Market Shares and Competitive Position by Product and Country--Performance, Capabilities, Goals and Strategies This unique market intelligence report provides ...

  • Diagnostics
  • Infectious Disease
  • Pathology
  • Germany
  • Demand

2020 Abbott: US, Europe, Japan--Diagnostics Market Shares and Competitive Position by Product and Country--Performance, Capabilities, Goals and Strategies

  • $ 2450
  • July 2020
  • 214 pages

2020 Abbott: US, Europe, Japan--Diagnostics Market Shares and Competitive Position by Product and Country--Performance, Capabilities, Goals and Strategies This unique market intelligence report provides ...

  • Diagnostics
  • Pathology
  • Germany
  • Demand
  • Market Shares

High-Grade Glioma - Epidemiology Forecast - 2030

  • $ 3750
  • July 2020
  • 100 pages

‘High-grade Glioma (HGG) - Epidemiology Forecast–2030’ report delivers an in-depth understanding of the disease, historical and forecasted High-grade Glioma (HGG) epidemiology in the United States, ...

  • Cancer
  • Diagnostic Imaging
  • Pathology
  • Germany
  • United States

Contact Dermatitis (CD) - Epidemiology Forecast–2030

  • $ 3750
  • July 2020
  • 100 pages

‘Contact Dermatitis (CD) - Epidemiology Forecast–2030’ report delivers an in-depth understanding of the disease, historical and forecasted Contact Dermatitis (CD) epidemiology in the United States, ...

  • Dermatological Condition
  • Pathology
  • Germany
  • United Kingdom
  • United States

Acute Myeloid Leukemia - Epidemiology Forecast to 2029

  • $ 3995
  • June 2020
  • 37 pages

Acute Myeloid Leukemia - Epidemiology Forecast to 2029 Summary Acute myeloid leukemia (AML) is a cancer of the blood and bone marrow in which the bone marrow produces abnormal red blood cells, white blood ...

  • Cancer
  • Epidemiology
  • Leukemia
  • Pathology
  • Germany

Hodgkin Lymphoma - Epidemiology Forecast to 2029

  • $ 3995
  • June 2020
  • 44 pages

Hodgkin Lymphoma - Epidemiology Forecast to 2029 Summary Epidemiologists used age- and sex-specific diagnosed incidence and prevalence rates to forecast the diagnosed incident and prevalent cases, taking ...

  • Cancer
  • Hospital
  • Lymphoma
  • Pathology
  • Germany

2024 Germany Transfusion Diagnostic Analyzers and Reagent Market Forecasts for 40 Immunohematology and NAT Assays: Supplier Shares and Strategies, Emerging Technologies, Instrumentation and Opportunities

  • $ 3500
  • June 2020
  • 426 pages

2024 Germany Transfusion Diagnostic Analyzers and Reagent Market Forecasts for 40 Immunohematology and NAT Assays: Supplier Shares and Strategies, Emerging Technologies, Instrumentation and Opportunities This ...

  • Hepatitis
  • Infectious Disease
  • Pathology
  • Germany
  • Forecast

2024 Europe Transfusion Diagnostic Analyzers and Reagent Market Forecasts for 40 Immunohematology and NAT Assays: France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Latest Technologies and Instrumentation

  • $ 14500
  • June 2020
  • 600 pages

2024 Europe Transfusion Diagnostic Analyzers and Reagent Market Forecasts for 40 Immunohematology and NAT Assays: France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Latest Technologies ...

  • Infectious Disease
  • Pathology
  • Europe
  • Germany
  • Forecast

2024 Germany Blood Typing, Grouping and Infectious Disease NAT Screening Market: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 40 Tests, Technology and Instrumentation Review

  • $ 3500
  • June 2020
  • 430 pages

2024 Germany Blood Typing, Grouping and Infectious Disease NAT Screening Market: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 40 Tests, Technology and Instrumentation Review This ...

  • Infectious Disease
  • Pathology
  • Germany
  • Demand

2024 Europe Blood Typing, Grouping and Infectious Disease NAT Screening Market in France, Germany, Italy, Spain, UK: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 40 Tests, Technology and Instrumentation Review

  • $ 9500
  • June 2020
  • 630 pages

2024 Europe Blood Typing, Grouping and Infectious Disease NAT Screening Market in France, Germany, Italy, Spain, UK: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 40 Tests, ...

  • Infectious Disease
  • Pathology
  • Europe
  • France
  • Germany

2024 Germany Diagnostics Market Shares and Forecasts for 500 Tests

  • $ 3500
  • June 2020
  • 61 pages

2024 Germany Diagnostics Market Shares and Forecasts for 500 Tests: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, ...

  • Diagnostics
  • Infectious Disease
  • Pathology
  • Germany
  • Forecast

Persistent Epithelial Defect (PED) - Epidemiology Forecast - 2030

  • $ 3750
  • June 2020
  • 100 pages

‘Persistent Epithelial Disease (PED)– Epidemiology Forecast—2030’ report delivers an in-depth understanding of the Persistent Epithelial Disease, historical and forecasted epidemiology in the United ...

  • Pathology
  • France
  • Germany
  • Spain
  • United States

Treatment-resistant depression (TRD) - Epidemiology Forecast - 2030

  • $ 3750
  • June 2020
  • 100 pages

‘Treatment-resistant depression (TRD)– Epidemiology Forecast—2030’ report delivers an in-depth understanding of the Treatment-resistant depression, historical and forecasted epidemiology in the ...

  • Depression
  • Mental Health
  • Pathology
  • Therapy
  • Germany

2024 Germany Automated Microbiology Market for over 100 Molecular, Identification, Susceptibility, Culture, Urine Screening and Immunodiagnostic Tests

  • $ 3750
  • June 2020
  • 420 pages

2024 Germany Automated Microbiology Market for over 100 Molecular, Identification, Susceptibility, Culture, Urine Screening and Immunodiagnostic Tests: Competitive Strategies, Emerging Technologies, Latest ...

  • Infectious Disease
  • Pathology
  • Germany

2024 Europe Automated Microbiology Market for over 100 Molecular, Identification, Susceptibility, Culture, Urine Screening and Immunodiagnostic Tests

  • $ 12900
  • June 2020
  • 600 pages

2024 Europe Automated Microbiology Market for over 100 Molecular, Identification, Susceptibility, Culture, Urine Screening and Immunodiagnostic Tests: France, Germany, Italy, Spain, UK--Competitive Strategies, ...

  • Infectious Disease
  • Pathology
  • Europe
  • France
  • Germany

Rubella (German Measles) - Pipeline Review, H1 2020

  • $ 2000
  • May 2020
  • 40 pages

Rubella (German Measles) - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Rubella – Pipeline Review, H1 2020, provides an overview of the Rubella (Infectious ...

  • Infectious Disease
  • Pathology
  • Vaccine
  • Germany
  • Product Initiative

2020 Germany Tumor Marker Testing Market: Supplier Shares, Volume and Sales Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers

  • $ 2450
  • May 2020
  • 585 pages

2020 Germany Tumor Marker Testing Market: Supplier Shares, Volume and Sales Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers ...

  • Cancer
  • Pathology
  • Germany
  • Demand

Pompe Disease - Epidemiology Forecast to 2030

  • $ 3750
  • May 2020
  • 100 pages

‘Pompe Disease (PD) - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Pompe Disease in the United States, EU5 (Germany, ...

  • Mental Health
  • Neurological Disorder
  • Pathology
  • Germany
  • United Kingdom

Chronic Pancreatitis (CP)- Epidemiology Forecast to 2030

  • $ 3750
  • May 2020
  • 100 pages

‘Chronic Pancreatitis (CP)- Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease,historical &forecasted epidemiology of Chronic Pancreatitisin the United States, ...

  • Digestive System Disorder
  • Pathology
  • Germany
  • Japan
  • United States

Warm Autoimmune Hemolytic Anemia (WAIHA)- Epidemiology Forecast to 2030

  • $ 3750
  • May 2020
  • 100 pages

‘Warm Autoimmune Hemolytic Anemia (WAIHA)- Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Warm Autoimmune Hemolytic ...

  • Pathology
  • France
  • Germany
  • Italy
  • United Kingdom

Non-cystic Fibrosis Bronchiectasis (NCFB)- Epidemiology Forecast to 2030

  • $ 3750
  • May 2020
  • 100 pages

‘Non-cystic fibrosis bronchiectasis (NCFB) - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Non-cystic fibrosis bronchiectasis epidemiology ...

  • Chronic Disease
  • Cystic Fibrosis
  • Pathology
  • Respiratory Disease
  • Germany

Refractory Angina (RA)- Epidemiology Forecast to 2030

  • $ 3750
  • May 2020
  • 100 pages

‘Refractory Angina (RA) - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Refractory Angina epidemiology in the 7MM, i.e., the United ...

  • Angina
  • Chronic Disease
  • Pathology
  • Germany
  • United States

Frontotemporal Dementia (FTD)- Epidemiology Forecast to 2030

  • $ 3750
  • May 2020
  • 100 pages

‘Frontotemporal Dementia (FTD) - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Frontotemporal Dementia in the United ...

  • Mental Health
  • Neurological Disorder
  • Pathology
  • Germany
  • United States

Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC)— Epidemiology Forecast to 2030

  • $ 2850
  • May 2020
  • 100 pages

‘Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC)— Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted EGFR-NSCLC ...

  • Cancer
  • Lung Cancer
  • Pathology
  • Germany
  • United States

Programmed death-ligand 1 (PD-L1) Non-small Cell Lung Cancer (NSCLC) - Epidemiology Forecast to 2030

  • $ 2850
  • May 2020
  • 100 pages

‘Programmed death-ligand 1 (PD-L1) Non-small Cell Lung Cancer (NSCLC) - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted PD-L1 NSCLC ...

  • Cancer
  • Lung Cancer
  • Pathology
  • Germany
  • United States

Cellular-mesenchymal Epithelial Transition Factor (C-Met) Mutated Non-small Cell Lung Cancer (NSCLC)- Epidemiology Forecast to 2030

  • $ 2850
  • May 2020
  • 100 pages

‘Cellular-mesenchymal Epithelial Transition Factor (C-Met) Mutated Non-small Cell Lung Cancer (NSCLC)- Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical ...

  • Cancer
  • Lung Cancer
  • Pathology
  • Germany
  • United Kingdom

BRAF Mutated Non-small Cell Lung Cancer (NSCLC) - Epidemiology Forecast to 2030

  • $ 2850
  • May 2020
  • 100 pages

‘BRAF Mutated Non-small Cell Lung Cancer (NSCLC)- Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted BRAF Mutated NSCLC epidemiology ...

  • Lung Cancer
  • Pathology
  • France
  • Germany
  • Forecast

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on